The Baltics Pharma Report 2018
While Lithuania, Latvia and Estonia have a lot in common – small, high-income economies and Eurozone members situated on the Eastern coast of the Baltic Sea – it would be…
While Lithuania, Latvia and Estonia have a lot in common – small, high-income economies and Eurozone members situated on the Eastern coast of the Baltic Sea – it would be…
India can claim with some degree of force to be ‘the pharmacy to the world.’ Not only are Indian medicines consumed in the US and EU, but enterprising Indian companies…
Despite a tiny domestic market size, the Lithuanian life sciences sector is full of hidden surprises. Comprising four percent of the nation’s entire GDP, with one percent accounted for by…
With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are…
Serbia is not often considered a promising investment destination within Europe, far less for its healthcare and life science industries. Sluggish economic growth and a regulatory system unconducive to the…
As pharmaceutical and biotech products become more complex and the markets they serve more diverse, the healthcare logistics and distribution industry has had to consistently innovate and evolve to meet…
Building on our two recent reports on Switzerland, this special Part III edition of Healthcare & Life Sciences Review casts a broad eye over the myriad of niches and specializations…
With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, Canadians still lack universal drug coverage and Canadian health innovation has lagged behind that of…
With an admirable legacy of excellence behind it, Austria’s healthcare and life science industry is poised to take the next step and help make the country a genuine hub for…
Squirreled away right on the South-Eastern fringe of Europe, Bulgaria still has a tendency to be overlooked and underestimated by the uninitiated. Not so by the international pharmaceuticals industry, however,…
Transitioning out of a period of instability following the revolution of 2011, Tunisia has much to recommend it within its region. Comparative political stability and a geostrategic location as the…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the ecosystem of pharmaceutical companies in Ukraine, based on in-depth interviews conducted with leaders and pioneers across the value…
See our Cookie Privacy Policy Here